My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 4 Next >
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
Tags United Parcel Service Inc Finance NXP Semiconductors NV
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Tags Companies US: News Business
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Investment strategy Economy Morgan Stanley
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags Companies Breaking news Alzheimer's disease
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags Politics Business News Eisai Co Ltd
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Law and Regulation Biotechnology Health care industry
From CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
Tags TG Therapeutics Inc Business Levi Strauss & Co
From CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
Tags Market Insider Bloom Energy Corp Economy
From CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
Tags Asia Markets Biogen Inc Pharmaceuticals
From CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags Biogen Inc Biotechnology World News
From CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
Tags Breaking News: Markets Stock markets Devon Energy Corp
From CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
Tags Biotech and Pharmaceuticals Health & Science Science
From CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags Biotech and Pharmaceuticals Health & Science US: News
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
Tags ONEOK Inc Pharmaceuticals Biogen Inc
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Health & Science Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
Tags Western Alliance Bancorp Eli Lilly and Co Advanced Micro Devices Inc
From CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
Tags Health & Science Biotech and Pharmaceuticals Coronavirus
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags US: News Quanterix Corp U/S/ Economy
From CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Tags Health & Science Biotech and Pharmaceuticals Policy
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Biotechnology Health care industry Biogen Inc
From CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
Tags Breaking News: Business Biogen Inc Pharmaceuticals
From CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Tags Biogen Inc Pharmaceuticals Biotechnology
From CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
Tags Eisai Co Ltd Breaking News: Business Biotechnology
From CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
Tags Biotech and Pharmaceuticals Pharmaceuticals Biogen Inc
From CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
Tags Pharmaceuticals Biogen Inc Biotechnology
From CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
Tags Eisai Co Ltd Pandemics Breaking News: Business
From CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
Tags Breaking News: Business Epidemics Pandemics
From CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
Tags Biotech and Pharmaceuticals Coronavirus Health & Science
From CNBC.com News
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
Tags DraftKings Inc Market Insider Economy
From CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
Tags U/S/ Economy US Economy Policy
From CNBC.com News
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.